Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions

被引:33
作者
Spence, J. David [1 ]
机构
[1] Stroke Prevent & Atherosclerosis Res Ctr, London, ON N6G 2V2, Canada
关键词
D O I
10.1007/s11910-007-0020-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients at high risk of vascular events can reduce their risk by 75% to 80% through a combination of lifestyle changes and medical therapy. These include smoking cessation, a Mediterranean diet, daily exercise, maintaining a fit weight, moderate consumption of alcohol, effective control of blood pressure and diabetes, intensive treatment with lipid-lowering drugs and antiplatelet agents, and perhaps treatment with vitamins to lower homocysteine. Much of this is achieved primarily by the patient; physicians need to become better at assisting their patients in making lifestyle changes. Effective control of treatment-resistant hypertension can be improved by individualizing medical therapy to the underlying cause, based on measurement of plasma renin and aldosterone. Measurement of carotid plaque may be useful by providing feedback on the success of therapy.
引用
收藏
页码:42 / 48
页数:7
相关论文
共 88 条
[1]
Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions [J].
Al-Shali, K ;
House, AA ;
Hanley, AJG ;
Khan, HMR ;
Harris, SB ;
Mamakeesick, M ;
Zinman, B ;
Fenster, A ;
Spence, JD ;
Hegele, RA .
ATHEROSCLEROSIS, 2005, 178 (02) :319-325
[2]
Genetic variation in PPARG encoding peroxisome proliferator-activated receptor γ associated with carotid atherosclerosis [J].
Al-Shali, KZ ;
House, AA ;
Hanley, AJG ;
Khan, HMR ;
Harris, SB ;
Zinman, B ;
Mamakeesick, M ;
Fenster, A ;
Spence, JD ;
Hegele, RA .
STROKE, 2004, 35 (09) :2036-2040
[3]
Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
[4]
Blood pressure and lipid lowering in the prevention of stroke: A note to neurologists [J].
Amarenco, P .
CEREBROVASCULAR DISEASES, 2003, 16 :33-38
[5]
Vitamin B12 (cobalamin) deficiency in elderly patients [J].
Andrès, E ;
Loukili, NH ;
Noel, E ;
Kaltenbach, G ;
Ben Abdelgheni, M ;
Perrin, AE ;
Noblet-Dick, M ;
Maloisel, F ;
Schlienger, JL ;
Blicklé, JF .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (03) :251-259
[6]
Amiloride, a specific drug for hypertension in black people with T594M variant? [J].
Baker, EH ;
Duggal, A ;
Dong, YB ;
Ireson, NJ ;
Wood, M ;
Markandu, ND ;
MacGregor, GA .
HYPERTENSION, 2002, 40 (01) :13-17
[7]
Baker SK, 2001, CLIN INVEST MED, V24, P258
[8]
BHATT DL, 2006, IN PRESS N ENGL J ME
[9]
Biglieri E G, 1984, J Hypertens Suppl, V2, pS259
[10]
BONDA KH, 2006, NEW ENGL J MED, V354, P1578